Uso de citrato de clomifeno e hCG no tratamento de hipogonadismo secundário: uma revisão integrativa
DOI:
https://doi.org/10.34117/bjdv9n5-197Keywords:
hipogonadismo secundário, citrato de clomifeno, hCGAbstract
Atualmente, o hipogonadismo secundário é tratado com testosterona exógena. O Citrato de clomifeno (CC) e a gonadotrofina coriônica humana (hCG) estão sendo introduzidos de forma “off-label” como terapia, visto que apresentam menores efeitos colaterais e permitem a manutenção da espermatogênese. O presente estudo trata-se de uma Revisão Integrativa literatura a fim de avaliar o uso dessas medicações para o tratamento do hipogonadismo secundário. Foram encontrados 174 artigos no total, dos quais, após a leitura do texto completo, 9 foram incluídos para análise dos dados. Todos os artigos confirmam a ação benéfica do Citrato de Clomifeno e/ou hCG no tratamento do hipogonadismo secundário, seja em monoterapia ou combinados com outras medicações.
References
FINK, J. et al. Human chorionic gonadotropin treatment: a viable option for management of secondary hypogonadism and male infertility. Expert Review of Endocrinology & Metabolism, v. 16, n. 1, p. 1–8, 1 jan. 2021. https://pubmed.ncbi.nlm.nih.gov/33345656/
GADALLA, M. A. et al. Effect of clomiphene citrate on endometrial thickness, ovulation, pregnancy and live birth in anovulatory women: systematic review and meta-analysis. Ultrasound in Obstetrics & Gynecology, v. 51, n. 1, p. 64–76, 3 dez. 2017. https://pubmed.ncbi.nlm.nih.gov/29055102/
HABOUS, M. et al. Clomiphene citrate and human chorionic gonadotropin are both effective in restoring testosterone in hypogonadism: a short-course randomized study. BJU international, v. 122, n. 5, p. 889–897, 1 nov. 2018. https://pubmed.ncbi.nlm.nih.gov/29772111/
HELO, S. et al. A Randomized Prospective Double-Blind Comparison Trial of Clomiphene Citrate and Anastrozole in Raising Testosterone in Hypogonadal Infertile Men. The Journal of Sexual Medicine, v. 12, n. 8, p. 1761–1769, 1 ago. 2015. https://pubmed.ncbi.nlm.nih.gov/26176805/
KAMINETSKY, J. et al. Oral Enclomiphene Citrate Stimulates the Endogenous Production of Testosterone and Sperm Counts in Men with Low Testosterone: Comparison with Testosterone Gel. The Journal of Sexual Medicine, v. 10, n. 6, p. 1628–1635, jun. 2013. https://pubmed.ncbi.nlm.nih.gov/23530575/
LA VIGNERA, S. et al. Late-onset hypogonadism: the advantages of treatment with human chorionic gonadotropin rather than testosterone. The Aging Male, v. 19, n. 1, p. 34–39, 21 out. 2015. https://pubmed.ncbi.nlm.nih.gov/26488941/
MATSUMOTO, A. M. et al. Stimulation of spermatogenesis with recombinant human follicle-stimulating hormone (follitropin alfa; GONAL-f®): long-term treatment in azoospermic men with hypogonadotropic hypogonadism. Fertility and Sterility, v. 92, n. 3, p. 979–990, set. 2009. https://pubmed.ncbi.nlm.nih.gov/18930190/
MEDEIROS, S. F. DE; MEDEIROS, M. M. W. Y. DE. Modificações dos níveis de gonadotrofinas durante a vida reprodutiva. Revista Brasileira de Ginecologia e Obstetrícia, v. 29, p. 48–55, 1 jan. 2007.
https://www.scielo.br/j/rbgo/a/nnWbPWGQk4gPp6G9ZbKxdbv/?lang=pt
MOSKOVIC, D. J. et al. Clomiphene citrate is safe and effective for long-term management of hypogonadism. BJU International, v. 110, n. 10, p. 1524–1528, 28 mar. 2012. https://pubmed.ncbi.nlm.nih.gov/22458540/
ODUWOLE, O. O.; HUHTANIEMI, I. T.; MISRAHI, M. The Roles of Luteinizing Hormone, Follicle-Stimulating Hormone and Testosterone in Spermatogenesis and Folliculogenesis Revisited. International Journal of Molecular Sciences, v. 22, n. 23, p. 12735, 25 nov. 2021. https://pubmed.ncbi.nlm.nih.gov/34884539/
RAIVIO, T.; WIKSTRÖM, A. M.; DUNKEL, L. Treatment of gonadotropin-deficient boys with recombinant human FSH: long-term observation and outcome. European Journal of Endocrinology, v. 156, n. 1, p. 105–111, 1 jan. 2007. https://pubmed.ncbi.nlm.nih.gov/17218732/
RAMASAMY, R. et al. Testosterone supplementation versus clomiphene citrate for hypogonadism: an age matched comparison of satisfaction and efficacy. The Journal of Urology, v. 192, n. 3, p. 875–879, 1 set. 2014. https://pubmed.ncbi.nlm.nih.gov/24657837/
SOARES, A. H. et al. Effects of clomiphene citrate on male obesity-associated hypogonadism: a randomized, double-blind, placebo-controlled study. International Journal of Obesity (2005), v. 42, n. 5, p. 953–963, 1 jun. 2018. https://pubmed.ncbi.nlm.nih.gov/29777228/
TRINH, T. S. et al. Evaluating the Combination of Human Chorionic Gonadotropin and Clomiphene Citrate in Treatment of Male Hypogonadotropic Hypogonadism: A Prospective Study. Research and Reports in Urology, v. Volume 13, p. 357–366, jun. 2021. https://pubmed.ncbi.nlm.nih.gov/34164348/
YANG, L. et al. Application of hormonal treatment in hypogonadotropic hypogonadism: more than ten years experience. International Urology and Nephrology, v. 44, n. 2, p. 393–399, 1 abr. 2012. https://pubmed.ncbi.nlm.nih.gov/21989858/
